Über das Unternehmen
- Firmenname (rechtlich): Zhejiang Tiantai Pharmaceutical Co., Ltd
- Registrierungsland: China
- Adresse: NO.588,FENGZE ROAD, Tiantai, Zhejiang
- Anzahl der Mitarbeiter: 500 - 999
Beschreibung:
Founded in June 1998 with registered capital of RMB 75 million, Zhejiang Tiantai Pharmaceutical Co., Ltd. mainly specializes in manufacturing antibiotic and antifungal series APIs, with main products including Clindamycin HCl, Clindamycin Phosphate and Amphotericin B. A state-level high-tech enterprise with around 410 staff, the company's headquarters, located in Tiantai county in southeast Zhejiang Province, covers a total area of more than 40,000 square meters including 15,000 square meters of floor space.
Geschäftsaktivitäten
ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch)
HerstellerLohnhersteller (CMO)API-Hersteller
Absatzmärkte
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestine, Qatar, Saudi Arabia, Syria, Turkey, Yemen
- Northern Europe: Denmark, Estonia, Finland, Iceland, Ireland
Hauptprodukte/-dienstleistungen
Unsere Produkte & Dienstleistungen
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Certifications
CE
FDA
GMP
ISO
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen